Dr. Christine M. Bestvina
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
18 reported clinical trials
33 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage III
Stage IV
Stage II
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Christine M. Bestvina is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Christine M. Bestvina
Clinical Trial Related5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Christine M. Bestvina has experience with
- Pemetrexed
- Carboplatin
- Pembrolizumab
- Nivolumab
- Paclitaxel
- Docetaxel
Breakdown of trials Christine M. Bestvina has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine M. Bestvina specialize in?
Christine M. Bestvina focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Christine M. Bestvina currently recruiting for clinical trials?
Yes, Christine M. Bestvina is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Christine M. Bestvina has studied deeply?
Yes, Christine M. Bestvina has studied treatments such as Pemetrexed, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Christine M. Bestvina?
Apply for one of the trials that Christine M. Bestvina is conducting.
What is the office address of Christine M. Bestvina?
The office of Christine M. Bestvina is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.